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Loss of epithelial cell polarity and inflammation are hallmarks of breast cancer development. Although the 
association between the disruption of tissue polarity and inflammation has been demonstrated, we know little 
about how these two events are coupled.  Using the 3D co-culture model of mammary epithelial cells and 
monocytes, a recent study reveals a link between disruption of epithelial polarity and monocytes infiltration. 
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The establishment and maintenance of epithelial polarity 
is crucial for the integrity and function of mammary gland. 
Loss of mammary tissue polarity is associated with cancer 
development and progression [1, 2]. Disruption of the 
polarized epithelial tissue structure occurs at the early stage 
of breast cancer development. This event is associated with 
the activation of PI3K-Rac1 signaling pathway and the 
significant remodeling of tissue microenvironment. 
Inhibition of the PI3K-Rac1 pathway reprograms the 
non-polarized breast cancer cells to form polarized spheroids 
in a 3D culture model [3, 4]. Using the 3D culture assay, we 
found that disruption of polarized acinar structure is 
accompanied with increased production of reactive oxygen 
species (ROS) [5] (Figure 1A). ROS such as hydrogen 
peroxide, superoxide and the hydroxyl radical, are 
byproducts of normal metabolism through the electron 
transport chain. ROS and associated oxidative stress drive 
cancer development and progression by inducing oxidative 
damages in DNA, lipids, proteins and other cellular 
components [6, 7], but its function and regulation in the 
disruption of tissue polarity has not been determined.  
Treatment with antioxidant agents can reduce ROS levels 
and reprogram non-polarized breast cancer cells to form 
polarized spheroids in 3D culture, indicating that elevation of 
ROS is necessary to disrupt polarized acinar formation. We 
also found that introduction of a constitutively activated 
RAC1 is sufficient to induce ROS generation in mammary 
epithelial cells [5]. Activated RAC1 binds to and forms a 
complex with NOX1, a homolog of the phagocyte 
NADPH-oxidase component gp91phox. NOX1 has the 
capacity to transport electrons across the plasma membrane 
and to generate superoxide and other downstream ROS. 
Therefore, RAC1 may increase NOX1-dependent ROS 
generation. These results suggest that RAC1 is a potential 
regulator that integrates non-polarized tissue formation and 
ROS production (Figure 1B).   
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Macrophages comprise a major stromal component in the 
tumor microenvironment. The infiltration and differentiation 
of macrophages determine inflammation in malignant tissue, 
which in turn promote breast cancer development and 
progression [8, 9]. Infiltration of tumor-associated 
macrophages correlates with poor prognosis in breast cancer 
patients [10, 11]. Macrophage infiltration occurs at an early 
stage of breast cancer development [12, 13]; therefore, 
inhibition of early-stage events such as macrophage 
infiltration and chronic inflammation may offer a promising 
strategy to prevent or repress cancer progression. However, it 
remains a challenge to block cancer-associated macrophage 
infiltration without disturbing normal function of immune 
system. Using the 3D co-culture model developed in our 
group, we show that disruption of mammary tissue polarity 
leads to monocyte/macrophage infiltration during cancer 
development [5]. In addition, it has been reported that 
macrophages accumulate around the terminal end buds of 
mammary glands rather than near the polarized ductal 
epithelial cells [14, 15]. Mammary epithelial cells in the 
terminal end bud are multilayer and non-polarized. These 
results also suggest that macrophage infiltration is associated 
with loss of tissue polarity. Interestingly, reducing ROS 
levels in non-polarized mammary epithelial cells is sufficient 
to block THP-1 infiltration in 3D culture, indicating that 
ROS are important mediators of the cancer cell-monocyte 
interaction (Figure 1B). We show that ROS induce 
expression of multiple cytokine genes in non-polarized 
malignant cells [5]. These cytokines may promote recruitment 
and infiltration of monocytes/macrophages in 3D culture. 
The NF-κB pathway is a critical regulator of cytokine 
expression and macrophage infiltration [16]. The gene 
expression profile analysis and unbiased position weight 
matrices analysis (PWMA) [17] show that the NF-kB pathway 
is activated in non-polarized mammary epithelial cells [18]. 
ROS is a well-characterized regulator of the NF-κB pathway. 
These results suggest the ROS may modulate 
monocyte/macrophage infiltration by inducing the NF-κB 
pathway in mammary epithelial cells (Figure 1B). However, 
how aberrant activation of the NF-κB pathway in mammary 
epithelial cells induces macrophage infiltration still remains 
to be addressed.  
Given the crucial role of ROS in regulating epithelial cell 
polarity and macrophage infiltration, reducing ROS levels in 
mammary epithelial cells may be a promising strategy to 
inhibit cancer-associate inflammation and prevent cancer 
Figure 1. (A) A scheme showing the association of epithelial polarity and ROS 
production. (B) Summary overview of the signaling pathway in non-polarized breast cancer 
cells that induces macrophage infiltration. 
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development and progression.   
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